Warther Private Wealth’s Pfizer PFE Stock Holding History

Warther Private Wealth’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,691	Closed	-$245K	–	68
2023 Q2	$245K	Sell	6,691 -3,558	-35%	-$138K	0.17%	55
2023 Q1	$418K	Sell	10,249 -34,469	-77%	-$1.49M	0.32%	51
2022 Q4	$2.29M	Buy	44,718 +460	+1%	+$22.1K	1.72%	20
2022 Q3	$1.94M	Buy	44,258 +5,491	+14%	+$267K	1.53%	22
2022 Q2	$2.03M	Buy	38,767 +1,535	+4%	+$78.2K	1.48%	18
2022 Q1	$1.92M	Buy	37,232 +1,001	+3%	+$51.9K	1.25%	20
2021 Q4	$2.05M	Buy	36,231 +701	+2%	+$34.7K	1.52%	18
2021 Q3	$1.52M	Buy	35,530 +19,324	+119%	+$856K	1.36%	19
2021 Q2	$641K	Buy	+16,206	New	+$630K	0.62%	46

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Warther Private Wealth's PFE Position: Q3 2023 in Review

Warther Private Wealth sold out of Pfizer (PFE) in Q3 2023, closing a stake of 6,691 shares — an estimated $245K sold.

Warther Private Wealth first reported a position in PFE in Q2 2021 and held it in 9 quarters. The position peaked at $2.29M in Q4 2022. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Warther Private Wealth reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Warther Private Wealth sold 6,691 Pfizer shares in Q3 2023, an estimated $245K.
Warther Private Wealth first reported a position in Pfizer in Q2 2021 and held it in 9 quarters.
Warther Private Wealth's Pfizer position peaked at $2.29M in Q4 2022.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Warther Private Wealth's 13F filing for Q3 2023, filed 14 Nov 2023.